Global Molecular Imaging (MI) Equipment Growth Opportunities

Global Molecular Imaging (MI) Equipment Growth Opportunities

Development of Novel Radiopharmaceuticals and Technical Advancements in AI and Hybrid Systems Fuel the Growth Pipeline

RELEASE DATE
16-Feb-2022
REGION
North America
Research Code: PCA2-01-00-00-00
SKU: HC03506-NA-MT_26281
$4,950.00
In stock
SKU
HC03506-NA-MT_26281
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This research study presents an analysis of and growth opportunities for the global molecular imaging (MI) equipment market. It offers an in-depth analysis of the current trends, market size, revenue forecast (2022–2026), and market penetration of PET/CT, PET/MRI, SPECT, and SPECT/CT systems.

Each year, more than 36 million MI procedures are performed globally, increasing annually by 4 to 6%. However, problems such as exposure to radiation, longer scan time, and delayed diagnosis of diseases have emerged, drawing manufacturers’ attention to technology and equipment enhancements that reduce radiation dose while improving patient comfort during a scan. Other factors driving the evolution of MI equipment include an increase in the number of patients with cancer, cardiac diseases, and neurological ailments.

In 2020, the MI equipment market experienced a decline at the global level due to the supply challenges caused by the COVID-19 pandemic. However, a trend toward a return to the pre-pandemic status of the supply chains for MI equipment was evident in the last quarter of 2020, which resulted in clearing back-logs of equipment sales and significant increase in revenue from the year 2020 to 2021.

Increased demand for radio pharmaceuticals that are used in MI resulted in the in-house production of radioisotopes using local cyclotrons. Development of novel radioisotopes is expected to increase the use of MI equipment for new clinical applications including Alzheimer's, melanomas, and prostate cancers.

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Molecular Imaging (MI) Equipment Market

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Market Segmentation

Therapeutic Indications

Highlights

Key Competitors for the MI Equipment Market

Competitors in the MI Equipment Market by Product

Key Growth Metrics for the MI Equipment Market

Distribution Channels

MI Ecosystem—Present and Future

Market Opportunity and Segment Growth Trends

Trend—Increase in Cyclotrons Installed Base for In-house Production of Radiotracers

Next Opportunity for PET Scanning Is to Potentially Aid in the Diagnosis of AD

Growth Drivers for the MI Equipment Market

Growth Restraints for the MI Equipment Market

Forecast Assumptions

Revenue and Unit Shipment Forecast

Revenue Forecast by Region

Unit Shipment Forecast by Region

Revenue Forecast by Product

Unit Shipment Forecast by Product

Revenue and Unit Shipment Forecast Analysis by Product

Revenue and Unit Shipment Forecast Analysis by Region

Revenue and Unit Shipment Forecast Analysis by Region (continued)

Revenue and Unit Shipment Forecast Analysis by Region (continued)

Pricing Trends Forecast by Product

Pricing Trends and Forecast Analysis by Product

Competitive Environment

Revenue Share

Revenue Share Analysis

Revenue Share Analysis (continued)

Key Growth Metrics for the PET/CT Systems Segment

Revenue and Unit Shipment Forecast, PET/CT Systems Segment

Revenue Forecast by Region, PET/CT Systems Segment

Unit Shipment Forecast by Region, PET/CT Systems Segment

Revenue and Unit Shipment Forecast Analysis, PET/CT Systems Segment

Key Growth Metrics for the PET/MRI Systems Segment

Revenue and Unit Shipment Forecast, PET/MRI Systems Segment

Revenue Forecast by Region, PET/MRI Systems Segment

Unit Shipment Forecast by Region, PET/MRI Systems Segment

Revenue and Unit Shipment Forecast Analysis, PET/MRI Systems Segment

Key Growth Metrics for the SPECT Systems Segment

Revenue and Unit Shipment Forecast, SPECT Systems Segment

Revenue Forecast by Region, SPECT Systems Segment

Unit Shipment Forecast by Region, SPECT Systems Segment

Revenue and Unit Shipment Forecast Analysis, SPECT Systems Segment

Key Growth Metrics for SPECT/CT Systems Segment

Revenue and Unit Shipment Forecast, SPECT/CT Systems Segment

Revenue Forecast by Region, SPECT/CT Systems Segment

Unit Shipment Forecast by Region, SPECT/CT Systems Segment

Revenue and Unit Shipment Forecast Analysis—SPECT/CT Systems Segment

Growth Opportunity 1—Miniature and Portable PET/CT Systems for Smaller Healthcare Providers, Such as Standalone Imaging/Radiology Centers

Growth Opportunity 1—Miniature and Portable PET/CT Systems for Smaller Healthcare Providers, Such as Standalone Imaging/Radiology Centers (continued)

Growth Opportunity 2—Whole Body PET/CT for New Clinical Applications and Reduced Exposure to Radiation

Growth Opportunity 2—Whole Body PET/CT for New Clinical Applications and Reduced Exposure to Radiation (continued)

Growth Opportunity 3—AI Platforms in MI to Improve Patient Care

Growth Opportunity 3—AI Platforms in MI to Improve Patient Care

Growth Opportunity 4—MI to Enter New Therapeutic Areas

Growth Opportunity 4—MI to Enter New Therapeutic Areas (continued)

Growth Opportunity 5—Increased Adoption of Cyclotrons for In-House Production of Radionuclides

Growth Opportunity 5—Increased Adoption of Cyclotrons For In-house Production of Radionuclides (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

Legal Disclaimer

Related Research
This research study presents an analysis of and growth opportunities for the global molecular imaging (MI) equipment market. It offers an in-depth analysis of the current trends, market size, revenue forecast (2022–2026), and market penetration of PET/CT, PET/MRI, SPECT, and SPECT/CT systems. Each year, more than 36 million MI procedures are performed globally, increasing annually by 4 to 6%. However, problems such as exposure to radiation, longer scan time, and delayed diagnosis of diseases have emerged, drawing manufacturers’ attention to technology and equipment enhancements that reduce radiation dose while improving patient comfort during a scan. Other factors driving the evolution of MI equipment include an increase in the number of patients with cancer, cardiac diseases, and neurological ailments. In 2020, the MI equipment market experienced a decline at the global level due to the supply challenges caused by the COVID-19 pandemic. However, a trend toward a return to the pre-pandemic status of the supply chains for MI equipment was evident in the last quarter of 2020, which resulted in clearing back-logs of equipment sales and significant increase in revenue from the year 2020 to 2021. Increased demand for radio pharmaceuticals that are used in MI resulted in the in-house production of radioisotopes using local cyclotrons. Development of novel radioisotopes is expected to increase the use of MI equipment for new clinical applications including Alzheimer's, melanomas, and prostate cancers.
More Information
No Index No
Podcast No
Author Vishnu Bhargav Yanamandra
Industries Healthcare
WIP Number PCA2-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9825-B1,9A06-B1,9566-B1,9570-B1,99CC-B1,99BE-B1,9614-B1